Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii
Descripción del Articulo
Background: Acinetobacter baumannii has become the most important pathogen responsible for nosocomial infections in health systems. It expresses several resistance mechanisms, including the production of β-lactamases, changes in the cell membrane, and the expression of efflux pumps. (2) Methods: A....
Autores: | , , , , , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2023 |
Institución: | Universidad Peruana de Ciencias Aplicadas |
Repositorio: | UPC-Institucional |
Lenguaje: | inglés |
OAI Identifier: | oai:repositorioacademico.upc.edu.pe:10757/668366 |
Enlace del recurso: | http://hdl.handle.net/10757/668366 |
Nivel de acceso: | acceso abierto |
Materia: | Acinetobacter baumannii antimicrobial resistance efflux pump inhibitors multidrug resistance Nosocomial infections β-lactamases PCR blaOXA-51-like gene Antimicrobial susceptibility Phenylalanine–arginine beta-naphthylamide (PAβN) Amikacin Quinolones and aminoglycosides Multidrug-resistant strains |
id |
UUPC_eda58a800a66055091d36a609ca1f5ee |
---|---|
oai_identifier_str |
oai:repositorioacademico.upc.edu.pe:10757/668366 |
network_acronym_str |
UUPC |
network_name_str |
UPC-Institucional |
repository_id_str |
2670 |
dc.title.es_PE.fl_str_mv |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
title |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
spellingShingle |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii Plasencia-Rebata, Stefany Acinetobacter baumannii antimicrobial resistance efflux pump inhibitors multidrug resistance Acinetobacter baumannii Nosocomial infections β-lactamases PCR blaOXA-51-like gene Antimicrobial susceptibility Phenylalanine–arginine beta-naphthylamide (PAβN) Amikacin Quinolones and aminoglycosides Multidrug-resistant strains |
title_short |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
title_full |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
title_fullStr |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
title_full_unstemmed |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
title_sort |
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii |
author |
Plasencia-Rebata, Stefany |
author_facet |
Plasencia-Rebata, Stefany Levy-Blitchtein, Saul del Valle-Mendoza, Juana Silva-Caso, Wilmer Peña-Tuesta, Isaac Vicente Taboada, William Barreda Bolaños, Fernando Aguilar-Luis, Miguel Angel |
author_role |
author |
author2 |
Levy-Blitchtein, Saul del Valle-Mendoza, Juana Silva-Caso, Wilmer Peña-Tuesta, Isaac Vicente Taboada, William Barreda Bolaños, Fernando Aguilar-Luis, Miguel Angel |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Plasencia-Rebata, Stefany Levy-Blitchtein, Saul del Valle-Mendoza, Juana Silva-Caso, Wilmer Peña-Tuesta, Isaac Vicente Taboada, William Barreda Bolaños, Fernando Aguilar-Luis, Miguel Angel |
dc.subject.es_PE.fl_str_mv |
Acinetobacter baumannii antimicrobial resistance efflux pump inhibitors multidrug resistance Acinetobacter baumannii Nosocomial infections β-lactamases PCR blaOXA-51-like gene Antimicrobial susceptibility Phenylalanine–arginine beta-naphthylamide (PAβN) Amikacin Quinolones and aminoglycosides Multidrug-resistant strains |
topic |
Acinetobacter baumannii antimicrobial resistance efflux pump inhibitors multidrug resistance Acinetobacter baumannii Nosocomial infections β-lactamases PCR blaOXA-51-like gene Antimicrobial susceptibility Phenylalanine–arginine beta-naphthylamide (PAβN) Amikacin Quinolones and aminoglycosides Multidrug-resistant strains |
description |
Background: Acinetobacter baumannii has become the most important pathogen responsible for nosocomial infections in health systems. It expresses several resistance mechanisms, including the production of β-lactamases, changes in the cell membrane, and the expression of efflux pumps. (2) Methods: A. baumannii was detected by PCR amplification of the blaOXA-51-like gene. Antimicrobial susceptibility to fluoroquinolones and aminoglycosides was assessed using the broth microdilution technique according to 2018 CLSI guidelines. Efflux pump system activity was assessed by the addition of a phenylalanine–arginine beta-naphthylamide (PAβN) inhibitor. (3) Results: A total of nineteen A. baumannii clinical isolates were included in the study. In an overall analysis, in the presence of PAβN, amikacin susceptibility rates changed from 84.2% to 100%; regarding tobramycin, they changed from 68.4% to 84.2%; for nalidixic acid, they changed from 73.7% to 79.0%; as per ciprofloxacin, they changed from 68.4% to 73.7%; and, for levofloxacin, they stayed as 79.0% in both groups. (4) Conclusions: The addition of PAβN demonstrated a decrease in the rates of resistance to antimicrobials from the family of quinolones and aminoglycosides. Efflux pumps play an important role in the emergence of multidrug-resistant A. baumannii strains, and their inhibition may be useful as adjunctive therapy against this pathogen. |
publishDate |
2023 |
dc.date.accessioned.none.fl_str_mv |
2023-07-31T17:22:45Z |
dc.date.available.none.fl_str_mv |
2023-07-31T17:22:45Z |
dc.date.issued.fl_str_mv |
2023-06-01 |
dc.type.es_PE.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
dc.identifier.doi.none.fl_str_mv |
10.3390/antibiotics12061071 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10757/668366 |
dc.identifier.eissn.none.fl_str_mv |
20796382 |
dc.identifier.journal.es_PE.fl_str_mv |
Antibiotics |
dc.identifier.eid.none.fl_str_mv |
2-s2.0-85163776142 |
dc.identifier.scopusid.none.fl_str_mv |
SCOPUS_ID:85163776142 |
dc.identifier.isni.none.fl_str_mv |
0000 0001 2196 144X |
dc.identifier.ror.none.fl_str_mv |
047xrr705 |
identifier_str_mv |
10.3390/antibiotics12061071 20796382 Antibiotics 2-s2.0-85163776142 SCOPUS_ID:85163776142 0000 0001 2196 144X 047xrr705 |
url |
http://hdl.handle.net/10757/668366 |
dc.language.iso.es_PE.fl_str_mv |
eng |
language |
eng |
dc.relation.url.es_PE.fl_str_mv |
https://www.mdpi.com/2079-6382/12/6/1071 |
dc.rights.es_PE.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.*.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.format.es_PE.fl_str_mv |
application/pdf |
dc.publisher.es_PE.fl_str_mv |
MDPI |
dc.source.es_PE.fl_str_mv |
Universidad Peruana de Ciencias Aplicadas (UPC) Repositorio Academico - UPC |
dc.source.none.fl_str_mv |
reponame:UPC-Institucional instname:Universidad Peruana de Ciencias Aplicadas instacron:UPC |
instname_str |
Universidad Peruana de Ciencias Aplicadas |
instacron_str |
UPC |
institution |
UPC |
reponame_str |
UPC-Institucional |
collection |
UPC-Institucional |
dc.source.journaltitle.none.fl_str_mv |
Antibiotics |
dc.source.volume.none.fl_str_mv |
12 |
dc.source.issue.none.fl_str_mv |
6 |
bitstream.url.fl_str_mv |
https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/5/antibiotics-12-01071-v2.pdf.jpg https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/4/antibiotics-12-01071-v2.pdf.txt https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/3/license.txt https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/2/license_rdf https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/1/antibiotics-12-01071-v2.pdf |
bitstream.checksum.fl_str_mv |
000a7fe3285e3ecc7d0e1ef2bb1b5f10 e7813e1e1a4f6de7c96dac02d582c06c 8a4605be74aa9ea9d79846c1fba20a33 4460e5956bc1d1639be9ae6146a50347 ac4b3c25c3b683d4e4d7951a5b1f95f8 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio académico upc |
repository.mail.fl_str_mv |
upc@openrepository.com |
_version_ |
1845545775878111232 |
spelling |
559895024e474f611f43ce45b0629bef77ddc5c1001d14b1dd13962134bd9cfb500046d5851c4dd69c686f2b4eb242288d1c91570ccc20664e384fad118e0923d7b7c70469ae1ea5c73befad8f4e2bbf2b450073b8f8160dbacb6351c2fe8c0be762e0a40c821b3d3c872ffd0d659a71deb1e99432e54b65fd730068d6cc43a4e22ec4500Plasencia-Rebata, StefanyLevy-Blitchtein, Sauldel Valle-Mendoza, JuanaSilva-Caso, WilmerPeña-Tuesta, IsaacVicente Taboada, WilliamBarreda Bolaños, FernandoAguilar-Luis, Miguel Angel2023-07-31T17:22:45Z2023-07-31T17:22:45Z2023-06-0110.3390/antibiotics12061071http://hdl.handle.net/10757/66836620796382Antibiotics2-s2.0-85163776142SCOPUS_ID:851637761420000 0001 2196 144X047xrr705Background: Acinetobacter baumannii has become the most important pathogen responsible for nosocomial infections in health systems. It expresses several resistance mechanisms, including the production of β-lactamases, changes in the cell membrane, and the expression of efflux pumps. (2) Methods: A. baumannii was detected by PCR amplification of the blaOXA-51-like gene. Antimicrobial susceptibility to fluoroquinolones and aminoglycosides was assessed using the broth microdilution technique according to 2018 CLSI guidelines. Efflux pump system activity was assessed by the addition of a phenylalanine–arginine beta-naphthylamide (PAβN) inhibitor. (3) Results: A total of nineteen A. baumannii clinical isolates were included in the study. In an overall analysis, in the presence of PAβN, amikacin susceptibility rates changed from 84.2% to 100%; regarding tobramycin, they changed from 68.4% to 84.2%; for nalidixic acid, they changed from 73.7% to 79.0%; as per ciprofloxacin, they changed from 68.4% to 73.7%; and, for levofloxacin, they stayed as 79.0% in both groups. (4) Conclusions: The addition of PAβN demonstrated a decrease in the rates of resistance to antimicrobials from the family of quinolones and aminoglycosides. Efflux pumps play an important role in the emergence of multidrug-resistant A. baumannii strains, and their inhibition may be useful as adjunctive therapy against this pathogen.Revisión por paresODS 3: Salud y BienestarODS 9: Industria, Innovación e InfraestructuraODS 17: Alianzas para lograr los objetivosapplication/pdfengMDPIhttps://www.mdpi.com/2079-6382/12/6/1071info:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Academico - UPCAntibiotics126reponame:UPC-Institucionalinstname:Universidad Peruana de Ciencias Aplicadasinstacron:UPCAcinetobacter baumanniiantimicrobial resistanceefflux pump inhibitorsmultidrug resistanceAcinetobacter baumanniiNosocomial infectionsβ-lactamasesPCRblaOXA-51-like geneAntimicrobial susceptibilityPhenylalanine–arginine beta-naphthylamide (PAβN)AmikacinQuinolones and aminoglycosidesMultidrug-resistant strainsEffect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumanniiinfo:eu-repo/semantics/article2023-07-31T17:22:46ZTHUMBNAILantibiotics-12-01071-v2.pdf.jpgantibiotics-12-01071-v2.pdf.jpgGenerated Thumbnailimage/jpeg101284https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/5/antibiotics-12-01071-v2.pdf.jpg000a7fe3285e3ecc7d0e1ef2bb1b5f10MD55falseTEXTantibiotics-12-01071-v2.pdf.txtantibiotics-12-01071-v2.pdf.txtExtracted texttext/plain52837https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/4/antibiotics-12-01071-v2.pdf.txte7813e1e1a4f6de7c96dac02d582c06cMD54falseLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53falseCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52falseORIGINALantibiotics-12-01071-v2.pdfantibiotics-12-01071-v2.pdfapplication/pdf800343https://repositorioacademico.upc.edu.pe/bitstream/10757/668366/1/antibiotics-12-01071-v2.pdfac4b3c25c3b683d4e4d7951a5b1f95f8MD51true10757/668366oai:repositorioacademico.upc.edu.pe:10757/6683662024-07-19 00:42:09.514Repositorio académico upcupc@openrepository.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 |
score |
13.754011 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).